LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Transcelerate Biopharma Inc.
Headquarters:
Conshohocken, PA, United States
Website:
http://www.transceleratebio...
Year Founded:
2012
Status:
Non-biopharma
Biopharma related deals can be found by searching the organization's name in the
Deals
Module.
BioCentury
|
Oct 17, 2022
Management Tracks
Baranowski becomes CEO at Avalyn
Plus new CMO at Ankyra as Kaufman becomes CEO, and updates from Verge, Zentalis, Aviceda and more
Read More
BioCentury
|
Apr 9, 2022
Finance
5AM refuels, with eye toward new set of opportunities
As Levy, Soteropoulos join team, veteran early-stage investor has $750M in new funds to deploy
Read More
BioCentury
|
Mar 18, 2022
Product Development
What’s holding back biopharma data science, and how to fix it
A survey by BioCentury and Owkin points to standardization as a top challenge, and highlights the debate on data centralization
Read More
BioCentury
|
Oct 27, 2021
Regulation
How Woodcock has changed FDA
In 35 years at FDA, Janet Woodcock has reshaped the way drugs are regulated and developed
Read More
BioCentury
|
Oct 13, 2021
Management Tracks
Stoffels ushered in half a dozen blockbusters for J&J
And nearly as many HIV drugs, plus one of the first COVID-19 vaccines
Read More
BioCentury
|
Mar 19, 2021
Product Development
Pandemic response ushers in new era of biopharma data sharing: Guest Commentary
The COVID R&D Alliance tells the story of a pharma data sharing initiative that could extend beyond COVID-19
Read More
BioCentury
|
Oct 30, 2020
Product Development
TransCelerate looks to sustain momentum of data sharing post-pandemic
TransCelerate adds clinical trial conduct, real world data and pharmacovigilance agreement initiatives to its data sharing platform
Read More
BioCentury
|
Sep 10, 2020
Product Development
Having touched the third rail of data sharing in the pandemic, drug developers should hold on tight
COVID-19 has lit a path to greater data sharing
Read More
BioCentury
|
Sep 7, 2020
Product Development
Back to School 2020: The imperative of COVID-19 — biopharma’s once-in-a-generation chance for change
BioCentury calls on industry to convert its COVID response to a new era of efficient drug development and address the urgent healthcare chasms exposed by the crisis
Read More
BioCentury
|
Aug 8, 2020
Product Development
Data sharing in and after COVID, with Takeda’s Anne Heatherington: a BioCentury podcast
Read More
Items per page:
10
1 - 10 of 47